Veru got screwed by the FDA. They didn't talk about any of the good things the drug does. It sounded like the FDA didn't want this to pass.
The drug has no side effects, doesn't make sense to not approve it and save lives.
The drug also states hospital visits are cut in half, cancer patients get 7 times the dose COVID patients get.
None of this was in the presentation.
The presentation was total Bullshit, it was a setup to say no.
Also the idiots that said no are not informed and hardly know anything about the drug.
It was a total shytshow, as usual our government sticking it to it's people they are supposably trying to protect.
All bullshit.
The drug has no side effects, doesn't make sense to not approve it and save lives.
The drug also states hospital visits are cut in half, cancer patients get 7 times the dose COVID patients get.
None of this was in the presentation.
The presentation was total Bullshit, it was a setup to say no.
Also the idiots that said no are not informed and hardly know anything about the drug.
It was a total shytshow, as usual our government sticking it to it's people they are supposably trying to protect.
All bullshit.
Recent VERU News
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 05/13/2026 01:19:42 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2026 01:09:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2026 11:00:07 AM
- Veru Reports Fiscal 2026 Second Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress • GlobeNewswire Inc. • 05/13/2026 10:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/06/2026 09:10:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/06/2026 08:59:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/06/2026 08:45:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/06/2026 08:34:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/06/2026 08:20:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/06/2026 08:10:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/06/2026 07:59:51 PM
- Veru to Report Fiscal 2026 Second Quarter Financial Results on May 13th • GlobeNewswire Inc. • 05/06/2026 12:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/16/2026 04:15:18 AM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 04/07/2026 08:18:22 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 04/07/2026 08:11:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/13/2026 08:04:22 PM
- Veru Enrolls First Patient in Phase 2b PLATEAU Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss • GlobeNewswire Inc. • 03/09/2026 12:30:00 PM
- Veru to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference • GlobeNewswire Inc. • 02/19/2026 01:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/11/2026 03:32:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/11/2026 12:00:14 PM
- Veru Reports Fiscal 2026 First Quarter Financial Results and Clinical Program Progress • GlobeNewswire Inc. • 02/11/2026 11:30:00 AM
- Veru to Report Fiscal 2026 First Quarter Financial Results on February 11th • GlobeNewswire Inc. • 02/04/2026 01:30:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 01/28/2026 09:07:48 PM
